Search

everythinglearnresearchcommunity

for

Search:↓

Skin and nail problems like hair loss, dry skin, and fungal infections are common in people with long-term Type 2 Diabetes and can be prevented with good blood sugar control and foot care.

Urinary Se to creatinine ratio, serum Se, and glutathione peroxidase are effective early biomarkers for selenium status in dogs.

Chronic ethanol increases certain brain receptor levels, influenced by steroids and protein changes.

Enzymatic phosphorylation of hair keratin improves the effectiveness of hair products with cationic ingredients.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

New hair loss treatments have evolved from understanding hair biology and patient needs.

Nilotinib can cause skin issues like red bumps and hair loss.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Disrupted sleep patterns can harm skin and hair cell renewal, but melatonin might help.

Ruxolitinib treatment may cause eyelash growth.

A woman's hair turned white after taking a cancer drug called dasatinib.

Claudin expression changes help the skin respond to injury.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Tofacitinib may effectively treat folliculitis decalvans.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.